Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

U.S. Stem Cell Inc. (USRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,286
  • Shares Outstanding, K 341,290
  • Annual Sales, $ 3,080 K
  • Annual Income, $ -2,070 K
  • 36-Month Beta 7.76
  • Price/Sales 4.18
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/19/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0246 +36.18%
on 11/17/17
0.0560 -40.18%
on 11/28/17
+0.0060 (+21.82%)
since 11/15/17
3-Month
0.0176 +90.34%
on 09/19/17
0.0560 -40.18%
on 11/28/17
+0.0141 (+72.68%)
since 09/15/17
52-Week
0.0018 +1,761.11%
on 12/23/16
0.1793 -81.32%
on 03/28/17
+0.0315 (+1,575.00%)
since 12/15/16

Most Recent Stories

More News
Degenerative Disc Patients Significantly Improve with USRM's Adipocell(TM)

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Chief Science...

USRM : 0.0335 (-6.94%)
U.S. Stem Cell Responds to FDA's Regenerative Medicine Guidelines

U.S. Stem Cell, Inc. (OTC: USRM), a leader in development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to the recently-announced...

USRM : 0.0335 (-6.94%)
U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds

SUNRISE, FL / ACCESSWIRE / August 28, 2017 / The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic (USCC), a privately-held Florida LLC and leader in novel regenerative...

USRM : 0.0335 (-6.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Key Turning Points

2nd Resistance Point 0.0439
1st Resistance Point 0.0400
Last Price 0.0335
1st Support Level 0.0321
2nd Support Level 0.0281

See More

52-Week High 0.1793
Fibonacci 61.8% 0.1115
Fibonacci 50% 0.0905
Fibonacci 38.2% 0.0696
Last Price 0.0335
52-Week Low 0.0018

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.